The role of narrowband UV-B plus alefacept combination therapy in the treatment of psoriasis.
Jacobe
Heidi
H
Winterfield
Laura
L
Kim
Flora
F
Huet-Adams
Beverley
B
Cayce
Rachael
R
D000077944:Alefacept; D000704:Analysis of Variance; D003131:Combined Modality Therapy; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage*; D012720:Severity of Illness Index; D012867:Skin / Q000473:pathology; D013223:Statistics as Topic; D014467:Ultraviolet Therapy
D007155:Immunologic Factors; D011993:Recombinant Fusion Proteins; D000077944:Alefacept